Kaken Pharmaceutical Co., Ltd. (TYO:4521)

Japan · Delayed Price · Currency is JPY

3,790.00

-30.00 (-0.79%)

Aug 4, 2026, 11:14 AM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Real Estate	2.54B	2.48B	2.43B	2.42B	2.41B
Pharmaceutical Industry	74.33B	91.55B	69.61B	70.56B	73.62B
Total	76.87B	94.03B	72.04B	72.98B	76.03B

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Japan	64.03B	67.43B	72.04B	72.98B	76.03B
North America (excl. United States)	400.00M	-	-	-	-
Others	479.00M	518.00M	-	-	-
Europe	89.00M	-	-	-	-
Asia	2.85B	3.81B	-	-	-
United States	9.02B	-	-	-	-
North America	-	4.13B	-	-	-
Europe (excl. Switzerland)	-	4.77B	-	-	-
Switzerland	-	13.38B	-	-	-
Total	76.87B	94.03B	72.04B	72.98B	76.03B